27 results
8-K
EX-99.1
RCEL
AVITA Medical Inc
9 Nov 23
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
4:09pm
of original burns market
Plan to actively identify new international distributor partnerships, including Australia, Japan, and European Union, over the next
8-K
EX-10.1
1um0e7 51ha6m71xu
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
424B5
dyda 1ynq8s
18 Oct 23
Prospectus supplement for primary offering
9:04am
10-KT
1f4cadu3s8vuy ob
28 Feb 22
Annual report (with FYE transition)
4:11pm
8-K
EX-1.1
lnkr2h 91ebnka5np
1 Mar 21
Avita Medical, Inc. Announces Pricing of Its Public Offering of
4:05pm
424B5
464bg00dh6pslt 7j
26 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
t6pdpu
24 Feb 21
Prospectus supplement for primary offering
4:04pm
10-K
nb047 y6c
27 Aug 20
Annual report
12:00am
8-K12B
EX-14.1
web40 gcaj
30 Jun 20
Notification of registration of securities
9:07am
6-K
EX-99.2
0pfmmisb usqaeklso02
12 May 20
Current report (foreign)
11:00am
6-K
EX-99.1
f1suppr
3 Feb 20
AVITA Medical Reports Second Quarter Fiscal 2020
12:27pm
6-K
EX-99.1
i6c8tr6 4vftwae
1 Nov 19
AVITA Medical Reports First Quarter Fiscal 2020
12:00am
20-F
127wg9mjcuwl506uf
31 Oct 19
Annual report (foreign)
3:49pm